Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Feature

Article

August 26, 2024

Heal

Heal Fall 2024
Volume11
Issue 02

Focusing Energy on Cancer-Related Fatigue

Author(s):

Ashley Chan

Key Takeaways

  • Hepatosplenic T-cell lymphoma is a rare, aggressive cancer affecting adolescents and young adults, often leading to chronic fatigue post-treatment.
  • Cancer-related fatigue persists despite rest, affecting daily life, and is common among survivors, especially those who underwent chemotherapy.
  • Effective management includes exercise, energy conservation, and mindfulness practices, as outlined in ASCO-SIO guidelines.
  • Aerobic and resistance training, alongside cognitive behavioral therapy, can help mitigate fatigue and improve quality of life for survivors.
SHOW MORE

Fatigue is a common side effect that may linger for years following cancer treatment. Experts and survivors talk about ways to help find a balance between life and fatigue.

Image of a woman with long hair next to a man, both smiling.

When CRAMER received his diagnosis, his mom left her career to be his full-time caregiver.

CRAMER, right, and his mom, ASHLEE, left.

As a college student and windsurfer on the Olympic development team, the sudden abnormal exhaustion Michael Cramer experienced revealed that something was very wrong. At age 19 in July 2020, Cramer and his mom, Ashlee, decided it was necessary for him to visit the hospital, despite the ongoing COVID-19 pandemic.

The next month, he received a diagnosis of hepatosplenic T-cell lymphoma. This subtype of lymphoma (a blood cancer) is considered rare, aggressive and is more common in adolescents and young adults, according to a study published in Blood.

Cramer received three rounds of chemotherapy, radiation and a bone marrow transplant from a donor in October. However, in January 2021, he developed graft-versus-host-disease (GVHD),

which occurs when the donated stem cells (graft) identify the patients’ cells (host) as a threat and attacks the host’s tissue, as defined by the Cleveland Clinic.

Four years later, Cramer, now 23, is in remission and receives immunosuppressants to help treat his GVHD. Still, he experiences cancer-related fatigue, which he says is likely from a mix of his cancer treatment and GVHD.

“Now I still deal with chronic fatigue as one of my main [side effects],” says Cramer, of Miami. “I get energy in spurts and bouts, but I always have to rest whenever we go somewhere to speak at a [cancer advocacy] event.”

His quality of life, he says, has been heavily affected by cancer-related fatigue. At times, he’ll wake up feeling motivated to have a productive day but realizes he’s only able to accomplish a few tasks because of intense fatigue. Completing smaller tasks now makes him feel more exhausted than they used to, he explains. After exercising for an hour, Cramer finds himself having to rest for a while once completing his repetitions.

“I just need to rest a lot more than I used to and need to take more time to sit down,” he says. “I don’t like sitting down a lot. I like to be very active, so it’s been hard for me to accept this. I try to push through, but then I end up very exhausted. It’s an interesting balance: figuring out whether I’m doing enough or doing too much.”

To add to the challenge, Cramer notes that his energy spurts come at random times during the day, which he tries to take advantage of. When these energy spurts align with his availability, he tries to use that time to work out and if it’s during the evening hours, he takes walks on the beach with his mom.

Ashlee — who left her career to become his caregiver full time — helps when he feels overly fatigued. She also advocates for him to rest when necessary because “she knows me and my fatigue so well,” Cramer says.

Now when he has those spurts of energy, he spends time with friends, challenges himself with Lego projects and creates content on social media with his mom about his cancer experience.

Understanding Cancer-Related Fatigue

Cancer-related fatigue is a common side effect most survivors experience, especially because it can be caused by both the cancer and its treatment, according to guidelines from the National Comprehensive Cancer Network. This type of fatigue may last months to years after the end of treatment and “does not improve with normal amounts of rest or sleep and disrupts daily life,” the guidelines state.

“Cancer-related fatigue is a fatigue that is pervasive throughout the body. The best way to describe it is the fatigue someone feels when they have the flu,” adds Luke Peppone, associate professor in the Department of Surgery, Cancer Control and Cancer Center at the University of Rochester in New York. “It’s not due to a lack of rest — additional rest does not alleviate this fatigue. When people have pervasive fatigue, it could be mental fatigue or physical.”

The source of cancer-related fatigue can vary, Peppone says. Almost all types of cancer treatments lead to some degree of fatigue, but chemotherapy contributes the most. Survivors who received chemotherapy for their cancer have “at least a 90% chance or greater of experiencing cancer-related fatigue,” Peppone says. When treatment ends, most people’s fatigue is alleviated within six months. However, in about 30% of survivors, he emphasizes that the fatigue doesn’t go away within six months and may last one to two years following treatment.

“Now the studies are being followed up longer and longer,” he says. “We find that five years out of treatment, 30% still have fatigue and even up to 10 years out now, as we extend the studies.”

Similarly, immunotherapy (a type of cancer treatment that helps the immune system destroy cancer) may also be related to cancer-related fatigue because the immune system can react against different organs, so survivors are “going to see some level of fatigue,” Peppone explains. Even nonintravenous therapies (treatments not infused through a vein), such as radiation and surgery, may cause some fatigue, but mostly because of the recovery process following these treatments, he says.

How Interventions Can Improve Cancer-Related Fatigue

Although cancer-related fatigue can alter quality of life and the way daily tasks are

completed, there are still ways to mitigate this side effect. Several practices to help manage cancer-related fatigue were updated in the 2024 American Society of Clinical Oncology (ASCO)-Society for Integrative Oncology (SIO) guidelines, which Peppone helped review. Based on further research, some interventions for fatigue were shown not to work, while many others were confirmed to be helpful.

“One thing not recommended during a person’s cancer experience is wakefulness agents (stimulants to help with alertness) and psychostimulants. So, no drugs [of that type] are recommended at all,” Peppone says.

A significant intervention that has been shown to help with managing cancer-related fatigue is exercise or a type of physical activity.

“There’s been evidence from the American College of Sports Medicine that doing 150 minutes of physical activity per week helps,” says Dr. Erin Kelly, director of Cancer Rehabilitation at Thomas Jefferson University Hospital in Philadelphia.

“I say physical activity because a lot of people don’t find exercise as something they enjoy, but some of our daily activities are really a form of exercise.”

However, Kelly notes that it may take a 12-week period or longer before survivors with fatigue notice the results, recommending 30 minutes of aerobic exercise at least three times a week. She explains that a breathlessness scale from zero to 10 helps indicate how much physical activity a person does and overall fitness. Aerobic exercise, specifically, is a 5 or 6 on the breathlessness scale, meaning a person can likely still talk but cannot sing, she says. Kelly says examples of aerobic exercise include a brisk walk or jogging.

Incorporating everyday physical activity doesn’t stop at aerobic exercise, though. Kelly explains that adding resistance training is important, but this doesn’t always mean lifting heavy weights; the key is repetition until it’s difficult to complete the next set of exercises.

“Being physically active is the best thing you can do to both prevent fatigue from occurring in the first place or treat it once it has occurred,” says Dr. Jennifer A. Ligibel, of the Breast Oncology Center at the Dana-Farber Cancer Institute and associate professor at Harvard Medical School, both in Boston. “It’s important to start slow so that you don’t wear yourself out, especially if you’re already experiencing fatigue.”

Completing exercise while feeling cancer-related fatigue can be a large ask, so Kelly agrees it’s necessary to build up to it. Instead of starting at 30 minutes, three times a week, she suggests starting at least once a week and asking a friend to join to make it more fun while having accountability. And you don’t have to necessarily start with exercise. Opt for an enjoyable physical activity, such as gardening, yoga, tai chi or meditation.

‘The Fatigue Just Takes You Out’

Image of a woman with a white blouse, standing in a park full of greenery.

DIANE HOLLAND, who works a full-time job, has learned how to balance receiving cancer treatment, chronic fatigue and work life.

When Diane Holland first experienced cancer-related fatigue, she had trouble determining whether she should build her stamina or rest. Now she goes on a walk and tries to push herself to do something physical daily. Like Cramer, Holland finds that her cancer-related fatigue varies each day.

Holland, 65, of Bensalem, Pennsylvania, has received four diagnoses for three cancer types since 2019. She first received a diagnosis of lung cancer in June 2019, for which she underwent surgery to remove the lower lobe of her left lung and was told she wouldn’t need further treatment. In December of that year, she was diagnosed with bladder cancer and underwent a procedure to remove the tumor. Following a routine mammogram, she received a diagnosis of breast cancer in 2021 and underwent a double mastectomy, chemotherapy, radiation and reconstructive surgery.

During the summer of 2023, she received her fourth diagnosis: a recurrence of her lung cancer. A full-time sales support employee at a multinational company, Holland says fatigue takes on a new meaning during treatment — mentally, physically and emotionally. Between appointments, working remotely and taking days off to recover from treatment, she has been able to balance her work life and fatigue. On the every other Tuesdays she receives chemotherapy, she takes the day off from work but is able to work the following two days after receiving steroids and antinausea medication. By Friday, she says the steroids wear off and she has to take another day off from work.

The level of fatigue Holland experiences from chemotherapy causes her to crash, which also affects the way she processes sound, she says.

“The fatigue just takes you out,” she explains. “It’s not just lying in bed, watching TV. I can’t really process the sounds. I just lay quietly, whether it’s in bed or on the sofa, just no sound.”

On posttreatment days when Holland’s fatigue is more manageable, she visits Kelly and a nutritionist at Jefferson hospital, where they discuss exercise and diet plans. Holland notes that trying several forms of integrative oncology, such as Reiki (a form of energy healing) and oncology massages, help her have some peace of mind. Her specialists have helped her manage fatigue, but Kelly has also helped change Holland’s mindset toward it.

“The most important thing that Dr. Kelly said to me is something that totally changed how I’m interacting with my fatigue,” Holland says. “She said, ‘You’re tired when you’re out and you’re tired when you’re home. Don’t let that stop you from going out to do the things you enjoy. Maybe just keep going out even though you feel tired and see if that brings you more energy.’

“It totally does. It was life-changing for me.”

Mitigating Cancer-Related Fatigue at Home

Energy conservation and using energy wisely are crucial, as Cramer and Holland both describe. Asking for help from loved ones is an effective way to help conserve energy, especially when there’s a task or event worth spending it on, Kelly emphasizes. Even getting help doing everyday tasks, such as laundry, may help.

“If people have cancer-related fatigue, energy conservation is something we talk about a lot,” Kelly says. “Try to conserve your energy to do the things you would like to do. Even if it’s someone else willing to help you do the laundry today because you’d rather go out and walk the dog. This can be taking that help and asking friends and family for favors for things that don’t give you joy and wouldn’t be adding to your physical fitness.”

Prioritizing how to spend each day by scheduling activities during energy spurts and delegating tasks to other people can help and is sometimes necessary, says Ligibel. Noticing trends in energy levels may also be helpful, particularly when completing tasks that require more energy, such as going grocery shopping. She notes that if a person feels more fatigued in the afternoon, then it may be best to structure their day around that.

Practicing mindfulness through cognitive behavioral therapy — another intervention listed in the ASCO-SIO guidelines — can be helpful, even online, Ligibel says.

“Seek out those opportunities for mindfulness because there’s data that it has been helpful,” she suggests. “Try to build that into your day because finding a quiet time and space for that — it’s not always so easy.”

Read the rest of the Heal Fall 2024 issue here.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Download Issue PDF
Articles in this issue

A young female exhausted character sitting in a chair with a low battery indicator above | Image credit: © - nadia_snopek © - stock.adobe.com
Powering Through Fatigue After Cancer
TEMPEH TIKKA MASALA: JÉRÔME ROMMÉ - STOCK.ADOBE.COM
Comforting Fall Recipes With Some Spice for Cancer Survivors
Image of a woman wearing a yellow leather jacket, hugging a dog.
A Metastatic Breast Cancer Survivor Finds Comfort in Social Media
Image of a woman with long hair next to a man, both smiling.
Focusing Energy on Cancer-Related Fatigue

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of doctor.
Image of Dr. Kelly
Image of Dr. Boffa.
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
image of doctor D'Sa
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
Image of doctor.
Picture of Dr. Pouneh Razavi
Image of man.
Image of Dr. Reznick
Related Content
Advertisement
Image of bladder.
May 15th 2025

Bladder Cancer Awareness Month Highlights the Importance of Early Detection

Ryan Scott
Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the disease.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Illustration of lungs.
May 15th 2025

Ventana MET RxDx Assay Receives FDA Approval as Companion Diagnostic in NSCLC

Ryan Scott
The FDA approved the Ventana MET RxDx assay, making it the first companion diagnostic to aid in determining MET protein expression in non-squamous NSCLC.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
"FDA" text
May 14th 2025

FDA Approves Emrelis in Previously Treated, Advanced NSCLC

Ryan Scott
The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met protein overexpression.
Aidixi plus toripalimab met study end points for patients with HER2-expressing urothelial carcinoma: © stock.adobe.com.
May 14th 2025

Aidixi Combination Therapy Improves Survival in Urothelial Carcinoma

Spencer Feldman
Aidixi plus toripalimab met progression-free and overall survival study end points versus chemo for patients with HER2-expressing urothelial carcinoma.
Related Content
Advertisement
Image of bladder.
May 15th 2025

Bladder Cancer Awareness Month Highlights the Importance of Early Detection

Ryan Scott
Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the disease.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Illustration of lungs.
May 15th 2025

Ventana MET RxDx Assay Receives FDA Approval as Companion Diagnostic in NSCLC

Ryan Scott
The FDA approved the Ventana MET RxDx assay, making it the first companion diagnostic to aid in determining MET protein expression in non-squamous NSCLC.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
"FDA" text
May 14th 2025

FDA Approves Emrelis in Previously Treated, Advanced NSCLC

Ryan Scott
The U.S. FDA has approved treatment with Emrelis for adult patients with previously treated, advanced NSCLC with high c-Met protein overexpression.
Aidixi plus toripalimab met study end points for patients with HER2-expressing urothelial carcinoma: © stock.adobe.com.
May 14th 2025

Aidixi Combination Therapy Improves Survival in Urothelial Carcinoma

Spencer Feldman
Aidixi plus toripalimab met progression-free and overall survival study end points versus chemo for patients with HER2-expressing urothelial carcinoma.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.